Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:47:46 +0200Thu, 20 Jun 2024 14:35:00 +0200Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 32, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tafinlarHuman medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 32, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tafinlarThu, 20 Jun 2024 14:35:00 +0200Human medicineTafinlar-H-C-WS-0996 : EPAR - Assessment Report - Variationhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500228171_en.pdfTafinlar-H-C-WS-0996 : EPAR - Assessment Report - Variationhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500228171_en.pdfMon, 22 May 2017 02:00:00 +0200Human medicine